This is a Phase 1 trial that aims to establish the safety of MORE-VR, as well as to collect feasibility, usability, and engagement data, for patients receiving medications for opioid use disorder (mOUD).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
34
Mindfulness-Oriented Recovery Enhancement therapy delivered over virtual reality.
Center on Mindfulness and Integrative Health Intervention Development
Salt Lake City, Utah, United States
Number of Participants With Adverse Events and/or Serious Adverse Events
Number of participants who reported adverse events and serious adverse events.
Time frame: Baseline through week 8
Engagement
Net Promoter Score (NPS) is a engagement and satisfaction measurement taken from asking participants how likely they were to recommend the MORE-VR intervention to others on a scale of 0-10. Net Promoter Score (NPS) is calculated by subtracting the percentage of customers who answer the NPS question with a 6 or lower (known as 'detractors') from the percentage of customers who answer with a 9 or 10 (known as 'promoters'). The summary Net Promoter Score is reflected as a percentage.
Time frame: Baseline through week 8
Numeric Rating Scale of State Craving
Craving measured on a 0 to 10 numeric rating scale, with 0 indicating no craving and 10 indicating extreme craving.
Time frame: Baseline through week 8
Numeric Rating Scale of State Positive Affect
Positive affect measured on a 0 to 10 numeric rating scale, with 0 indicating no positive affect and 10 indicating very high positive affect.
Time frame: Baseline through week 8
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.